These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 30712811)
21. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs. Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709 [TBL] [Abstract][Full Text] [Related]
22. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X; Liu R; Tang H; Jin M; Chen H; Qian P Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics. Li P; Bai X; Sun P; Li D; Lu Z; Cao Y; Fu Y; Bao H; Chen Y; Xie B; Liu Z BMC Vet Res; 2012 May; 8():57. PubMed ID: 22591597 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of vaccine efficacy with 2B/T epitope conjugated porcine IgG-Fc recombinants against foot-and-mouth disease virus. Song BM; Lee GH; Kang SM; Tark D J Vet Med Sci; 2024 Sep; 86(9):999-1007. PubMed ID: 39069487 [TBL] [Abstract][Full Text] [Related]
25. The VP1 G-H loop hypervariable epitope contributes to protective immunity against Foot and Mouth Disease Virus in swine. Fernandez-Sainz I; Gavitt TD; Koster M; Ramirez-Medina E; Rodriguez YY; Wu P; Silbart LK; de Los Santos T; Szczepanek SM Vaccine; 2019 Jun; 37(26):3435-3442. PubMed ID: 31085001 [TBL] [Abstract][Full Text] [Related]
26. Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain. Lloyd-Jones K; Mahapatra M; Upadhyaya S; Paton DJ; Babu A; Hutchings G; Parida S Vaccine; 2017 Dec; 35(49 Pt B):6842-6849. PubMed ID: 29102329 [TBL] [Abstract][Full Text] [Related]
27. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination. Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355 [TBL] [Abstract][Full Text] [Related]
28. Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection. Yang M; Xu W; Goolia M; Zhang Z Virol J; 2014 Aug; 11():136. PubMed ID: 25085313 [TBL] [Abstract][Full Text] [Related]
29. Rapid Engineering of Foot-and-Mouth Disease Vaccine and Challenge Viruses. Lee SY; Lee YJ; Kim RH; Park JN; Park ME; Ko MK; Choi JH; Chu JQ; Lee KN; Kim SM; Tark D; Lee HS; Ko YJ; Seo MG; Park JW; Kim B; Lee MH; Lee JS; Park JH J Virol; 2017 Aug; 91(16):. PubMed ID: 28566375 [TBL] [Abstract][Full Text] [Related]
30. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060 [TBL] [Abstract][Full Text] [Related]
31. A Vaccine Based on the A/ASIA/G-VII Lineage of Foot-and-Mouth Disease Virus Offers Low Levels of Protection against Circulating Viruses from the A/ASIA/Iran-05 lineage. Singanallur NB; Eblé PL; Ludi AB; Statham B; Bin-Tarif A; King DP; Dekker A; Vosloo W Viruses; 2022 Jan; 14(1):. PubMed ID: 35062300 [TBL] [Abstract][Full Text] [Related]
32. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Qian P; Li XM; Jin ML; Peng GQ; Chen HC Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769 [TBL] [Abstract][Full Text] [Related]
33. Antigenic and immunogenic spectrum of foot-and-mouth disease vaccine strain O Galdo Novo S; Malirat V; Maradei ED; Espinoza AM; Smitsaart E; Pedemonte AR; Mattion N; Bergmann IE Vaccine; 2017 Apr; 35(18):2303-2307. PubMed ID: 28343779 [TBL] [Abstract][Full Text] [Related]
34. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine. Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707 [TBL] [Abstract][Full Text] [Related]
35. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge. Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651 [TBL] [Abstract][Full Text] [Related]
36. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles. Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397 [TBL] [Abstract][Full Text] [Related]
37. Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa Foot-and-Mouth Disease monovalent vaccine and challenge in goats and comparison with sheep. Madhanmohan M; Nagendrakumar SB; Kumar R; Anilkumar J; Manikumar K; Yuvaraj S; Srinivasan VA Res Vet Sci; 2012 Oct; 93(2):1050-9. PubMed ID: 22079173 [TBL] [Abstract][Full Text] [Related]
38. New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014-2015. Jo HE; Ko MK; Choi JH; Shin SH; Jo H; You SH; Lee MJ; Kim SM; Kim B; Park JH J Vet Sci; 2019 Jul; 20(4):e42. PubMed ID: 31364326 [TBL] [Abstract][Full Text] [Related]
39. Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory. Paton DJ; Reeve R; Capozzo AV; Ludi A Vaccine; 2019 Sep; 37(37):5515-5524. PubMed ID: 31405637 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage. Waters R; Ludi AB; Fowler VL; Wilsden G; Browning C; Gubbins S; Statham B; Bin-Tarif A; Mioulet V; King DJ; Colenutt C; Brown E; Hudelet P; King DP Vaccine; 2018 Mar; 36(14):1901-1907. PubMed ID: 29506922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]